1. Van der Poel, Noel L, Barbara J, Dodd R. ISBT Working
party on transmisable diseases: Report on the workshop ‘
Infectious-disease testing and quality control. VOX Sang
1996; 70: 53-60
2. Kuehner MJ, Roth VR, Haley NR et al. Transfusion
transmitted bacterial infections in the United States 1998
through 2000. Transfusion 2001; 41: 1493-9
3. Blanjchman MA, Ali M, Richardson LH. Bacterial
contamination of cellular blood components VOX Sang
1994; 67: 23-33
4. Tabor E. Bacterial infections transmitted by blood
infectious complications of blood transfusion book
Academic Press. In. New York, 1982 ; 147-65
5. Sönmezoğlu M, Tranfüzyonla bulaşan sıtma. Sendrom
2002; 14: 115-8
6. Koff RS, Seeff LB, Distag JL: Transfusion transmitted
hepatitis A, B and D. Principles of Transfusion Medicine.
Second edition, Baltimore-Philadelphia-London, 1996;
675-86
7. Cenfers for Disease Control and Prevention Division of
HIV/AIDS Prevention-Basic Statis Lics. MMWR. 2201
8. Lackritz EM: Prevention of HIV transmission in the
developing world: Achievements and continuing
challenges. AIDS 1998; 12 (Suppln): 581-6
9. AIDS Savaşım Derneği. AIDS Savaşım Bülteni 2001;
40: 7
10. Dodd RY. Current viral risk of blood and blood products.
Ann Med 2000; 32: 469-74
11. Gerlich WH, Caspari G. Hepatitis viruses and the safety
of blood donations. S Viral Hep.1999; (suppl): 6-15
12. Screiber GB, Bush MP, Kleinman SH, et al. The risk of
transfusion-transmitted viral infections. The retrovirus
epidemiology donor study. Nengl J Med 1996; 334:1685-
90
13. Regam FAM, Prospective investigation of transfusion
transmitted infections in recipient of over 20000 units of
blood. Br Med J 2000; 320: 403-6
14. Koerner K, Cardosa M, Deryler T, et al. Estimated risk of
transmision of hepatitis C virus by blood transfusion.
VOX Sang 1998; 74: 213-6
15. Busch MP, Watanabe KK, Smith JVU, et al. False
negative testing errors inroutine viral marker screening of
Temmuz-Eylül 2003 KAN VE KAN ÜRÜNLERİYLE BULAŞAN İNFEKSİYONLAR; KOCAZEYBEK
163
blood donors. For the Retrovirus epidemiology donor
study. Transfusion. 2000; 40: 585-9
16. Gallarda JL, Dragon E. Blood screening by nucleic acid
amplification technology: Current issues, future
challenge. Mol Diagn 2000; 5: 11-22
17. Report of the Interorganizational Task Force on Nucleic
acid Amplification Testing of Blood Donors. Nucleic
acid testing of blood donors for transfusion-transmitted
infectious diseases. Transfusion 2000; 40: 143-59
18. EPFA/NIBSC Workshop. Nucleic acid amplification tests
for the detection of blood-bone viruses. VOX Sang 1999;
76: 194-200
19. Saldanha J. Validation and standardization of nucleic acid
amplification technology (NAT) an assay for the
detection of viral contamination of blood and blood
products. J Clin Virol 2001; 20: 7-13
20. Petrik J, Hevvitt P, Barbara J, et al. Large-scale HCVRNA
screening in first time blood donors; the first step
Towards Genomic Screening of blood donations. VOX
Sang 1999; 76:159-62
21. Roth WK, Buhr S, Drosten C, et al. NAT and viral safety
in blood transfusion. VOX Sang 2000; 78: 257-9
22. Rouziox C.,Barin F, Cazenave JP, et al. Contribution of
nucleic acid amplification techniques to the safety of
blood components in France. Transfusion 1998; 38: 989-
90
23. Seitz R, Burger R: Science, Lawyers, and the Europeans
testing requirements in transfusion medicine. Transfusion
1998; 38: 506
24. Mc Cullough J, Bianco C, Busch MP, et al. Genome
amplification Tash force. Prelinary report. Transfusion
1998; 38: 903-4
25. Kagom D, Levin AE, Rapid assay for bacterial
contamination of platelets. Transfusion 2002; 41 (suppl):
34
26. Mc Donald CP; Simith R; Colvin J, et al. Evaluation of a
novel dielectrophoresis system for the rapid detection of
bacteria in platelet concantrates. Transfusion 2001; 41
(suppl19): 34
27. Houghton Rh, Homer MS, Reynolds LD; et al. Peptide
ELI SA for detection of antibodies yo Babesia microti in
serum. Transfusion 2001; 41 (suppl 9):13
